PhD MPHe BSc(Hons) PGCHET FHEA
Director - Interdisciplinary Centre for Health, Wellbeing & Nutrition
- About
-
- Email Address
- lesley.anderson@abdn.ac.uk
- Office Address
- School/Department
- Senior Vice Principals
Biography
I am the University's Interdisciplinary Director for Health, Nutrition and Wellbeing and a Personal Chair in Health Data Science.
I trained at Queen's University Belfast (QUB) graduating with a PhD in cancer epidemiology in 2004 and an undergraduate degree (first class Honours) in Biomedical Science in 2001. I have a Masters in Population Health-based Evidence obtained by distance learning from the University of Manchester (distinction level) in 2006. I joined QUB as an academic in 2010 after completing two highly respected fellowships: an Academic Fellowship (funded by the UK Medical Research Council) and a Cancer Prevention Fellowship at the National Cancer Institute, National Institute of Health, Maryland, United States of America. I joined the Northern Ireland Cancer Registry (NICR) part-time in 2017 as Deputy Director overseeing the production of Official Statistics for Northern Ireland and developing the NICR Research Advisory Group.
I have over 24 years experience in research utilising healthcare data from across the globe. I have established international partnerships within the USA, Europe, Australia, Africa and Asia to facilitate research in the fields of health data science and public health with a focus on cancer research. Global Health Research Partnerships with researchers in Angola, Mongolia and Vietnam are seeking to identify ways to improve public knowledge and reduce the burden of cancer.
I was Grampian Academic Lead for the Industrial Centre for Artificial Intelligence in Digital Diagnostics (iCAIRD), a £25 million programme of research bringing together 40 academic, NHS and industrial partners. My current research is focusing on artificial intelligence evaluation and working with advanced health data science approaches to improve health care.
Qualifications
- PhD Public Health2004 - Queen's University BelfastTitle. The aetiology of Barrett's oesophagus and oesophageal adenocarcinoma: results from an all-Ireland case-control study.
- MPHe Population Health2006 - University of Manchester
- BSc (Hons) Biomedical Science2001 - Queen's University Belfast
- PGCHET Postgraduate Certificate in Higher Education Teaching2009 - Queen's University Belfast
Memberships and Affiliations
- Internal Memberships
-
- University Management Group (UMG), University of Aberdeen, 2024-date.
- Senate Academicus, University of Aberdeen (Oct 2022-Sept 2026).
- Aberdeen Centre for Health Data Science Senior Leadership Team (Sept 2020-date)
- External Memberships
-
- North of Scotland AI Strategy Regional Implementation Oversight Group (Apr 2024-date).
- External Programme and Module Examiner, Masters in Public Health, University of Manchester, 2019-2023.
- Cancer Research UK Prevention and Population Research Committee, Expert Review Panel (2022-date).
- Blood Cancer UK - Data themed Funding Committee (2022-date).
- Breast Cancer Now Tissue Bank Advisory Council (2021-date).
- National Cancer Research Institute Haematological Oncology Group member (2019-date)
Latest Publications
The Clinical Practice Integration of Artificial Intelligence (CPI-AI) framework: a proposed application of IDEAL principles to artificial intelligence applications in trauma and orthopaedics
Bone & Joint Research, vol. 13, no. 9, pp. 507-512Contributions to Journals: ArticlesTNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinoma
European Journal of Cancer, vol. 211, 114329Contributions to Journals: ArticlesTrends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021
Scientific Reports, vol. 14, no. 1, 19069Contributions to Journals: ArticlesPathways to MPN presentation and time-to-diagnosis: results from a cross-sectional study
BJGP OpenContributions to Journals: ArticlesAutoimmune Conditions and Gastric Cancer Risk in a Population-based Study in the United Kingdom
British Journal of Cancer, vol. 131, pp. 138-148Contributions to Journals: Articles
Prizes and Awards
- Abstract Award ‘Identifying the optimal AI workflow integration for breast screening’, EUSOBI 2024.
- Data Driven Innovation Award– iCAIRD, Digital Health and Care Awards, 2024.
- Positive Research Culture Award, Excellence Awards 2023, University of Aberdeen, 2023.
- Data Driven Innovation – iCAIRD for the implementation of our imaging research platforms (SHAIP and Pathology Living Lab). Holyrood Digital Health and Care Awards, 2023.
- iCAIRD won the Multiparty Collaboration Award at the Scottish Knowledge Exchange Awards in 2022.
- Innovative Collaboration Award: iCAIRD, Scotland’s Life Sciences Awards 2021.
- Outstanding Research Team – iCAIRD, Excellence Awards 2022, University of Aberdeen, 2022.
- Outstanding Research Project – Covid-19 Response & Recovery Award 2021, Excellence Awards 2021, University of Aberdeen, 20 21.
- STAR (STAff Recognition Scheme) for exceptional performance and contribution in your role. QUB, 2020.
- STAR (STAff Recognition Scheme) for exceptional performance and contribution in your role. QUB, 2019.
- Best Clinical Poster Prize, Haematology Association Ireland Annual Conference, October 2016.
- Presentation award. School of Medicine, Dentistry and Biomedical Sciences Postdoc Society Symposium, February 2010.
- Poster prize, Nursing and Allied Health Professional section, Cancer Recognised Research Group Retreat, September 2008.
- Dr J.D. Williamson Prize for best postgraduate medical research, Faculty of Medicine and Health Science, Queen’s University Belfast, 2007.
- Poster of Distinction. Digestive Disease Week, 2007.
- Highly commended for the BUPA Foundation Epidemiology Award, October 2005.
- Awarded best presentation at the Ulster Society of Gastroenterology meeting, October 2005.
- Travel scholarship for International Society of Gastrointestinal Oncology meeting, 2005.
- Digestive Disease Week Conference, May 2005. Platform presentation in the Distinguished Abstract Plenary Session. The abstract was noted as newsworthy.
- All Ireland Cancer Conference, 2003. Best poster prize.
- Awarded best presentation at the Ulster society of Gastroenterology meeting, March 2002
- Foundation Award, Queen’s University Belfast, 2001.
- Research
-
Research Overview
Health Data Research
Professor Anderson has over 19 years experience of using health data to research cancer and chronic disease epidemiology. Her research interests are aligned around the following research themes:
- Rare cancers
- Infection-related cancers
- Pre-cancerous conditions
- Chronic diseases
Research Areas
Accepting PhDs
I am currently accepting PhDs in Applied Health Sciences, Biomedical Sciences, Artificial Intelligence.
Please get in touch if you would like to discuss your research ideas further.
Research Specialisms
- Healthcare Science
- Biomedical Sciences
- Health Informatics
- Environmental and Public Health
- Oncology
Our research specialisms are based on the Higher Education Classification of Subjects (HECoS) which is HESA open data, published under the Creative Commons Attribution 4.0 International licence.
Current Research
Artificial Intelligence (AI) Evaluation
Projects looking to evaluate AI tools for translation into healthcare.
Funding from Friends of ANCHOR for a large comprehensive mammography database - ‘ANCHOR breast imaging dataset’ has been secured expanding potential to undertake AI evaluations in breast screening.
Cancer Prevention Research
Professor Anderson is leading the world's first nationwide case-control study of myeloproliferative neoplasms, the MOSAICC (MyelOproliferative neoplasmS: An In-depth Case-Control) study. The study is recruiting patients from across the United Kingdom and Ireland collecting information on potential risk factors (causes) and assessing the quality of life of these patients.
Past Research
MOSAICC pilot study - largest study of myeloproliferative neoplasms to date. Study designed to determine best methodological approach for a UK-wide study which is ongoing looking at the aetiology and impact of a MPN diagnosis.
FINBAR study - large all-Ireland case-control study of oesophageal cancer and precancerous conditions. This study has led to many publications looking at the aetiology of these oesophageal conditions and is part of an international collaboration - the BEACON consortium.
EUROCARE - I have worked with the EUROCARE consortium to undertake a range of studies looking at variations in the survival of oesophgeal, gastric, small intestine and head and neck cancer and haematological malignancies.
RARECARE - I have worked with European colleagues to look at thyroid cancers and the burden and centralised treatment in Europe of rare tumours.
HPV and Head and Neck cancer - study identified that p16 is an insufficient marker for stage classification of oropharyngeal cancer. The data from this study is being combined with wider cohorts to evaluate this further and to look at restaging of oropharyngeal cancer.
COELIAC DISEASE - A study that I led looking at gluten sensitivity and coeliac disease and outcomes (cancer and all-cause mortality) led to the identification of adverse outcomes for those with gluten sensitivity but without a confirmed coeliac diagnosis.
MOSAICC Study
There is little information about what causes myeloproliferative neoplasms (MPNs). Patients often ask, “why do I have this disease?”, and for the majority there is no obvious reason. The MOSAICC study (MyelOproliferative neoplasmS: An In-depth Case-Control) is a UK-wide study that aims to identify what causes myeloproliferative neoplasms (MPNs). The MOSAICC study is open in 19 sites across the UK and in Cork Ireland.
Collaborations
Professor Anderson is a member of the BEACON consortium (https://esocan.org/beacon/).
Professor Anderson has research collaborations with researchers in the UK, Ireland, USA, across Europe, Australia, Angola, Vietnam and Mongolia.
Supervision
My current supervision areas are: Applied Health Sciences, Biomedical Sciences, Artificial Intelligence.
PhD
- 2nd supervisor: “Enhancing long-term evaluation and monitoring of responsible AI deployments in medical context.” University of Aberdeen, 2024-2028. Funded: University of Aberdeen
- 1st supervisor: ‘What modifications could be made to the UK breast screening service with Artificial Intelligence (AI) approaches to improve service delivery and participant outcome?’ University of Aberdeen, 2024-2028. Funded: Self-funded
- 2nd supervisor (MD): ‘AI supported image analysis in large bowel camera capsule endoscopy (AICE).’ University of Aberdeen, 2023-2027. Funded: University of Aberdeen.
- 2nd supervisor: ‘Methods for the economic evaluation of artificial intelligence algorithms in breast cancer diagnosis.’ University of Aberdeen, 2023-2027. Funded: University of Aberdeen.
- 1st PhD supervisor: ‘Investigating the routes to diagnosis of Myeloproliferative Neoplasms using multidisciplinary approaches.’ University of Aberdeen, 2021-2025. Funded: University of Aberdeen.
- 1st PhD supervisor: ‘ARCHERY PROJECT: AI TO REVOLUTIONISE THE PATIENT CARE PATHWAY IN HIP AND KNEE ARTHROPLASTY’. University of Aberdeen, 2021-2024. Funded: Chief Scientist Office.
- 2nd PhD supervisor: ‘Investigating the significance of haematological malignancy precursors with a particular focus on multiple myeloma’, QUB 2019-2020. Funded: Dfe. Changed to 3rd supervisor when I changed job.
- 1st PhD supervisor: ‘Implementation of electronic cigarette policy in Kuwait.’ QUB 2016-2021. Funded: Kuwaiti government. Changed to 3rd supervisor when I changed job.
- 1st PhD supervisor: ‘Barriers to cervical cancer screening and diagnosis in Northern Ireland.’ QUB 2018-2021. Funded: Saudi/ Kuwaiti government. Changed to 3rd supervisor when I changed job.
- 1st PhD supervisor: ‘Assessing the impact of hydroxyurea treatment for children with sickle cell anaemia in Cabinda province, Angola.’ QUB 2016-2020. Funded: Angolan government.
- 1st PhD supervisor: ‘Assessing the impact of MGUS’, QUB 2015-date. Funded: DEL.
- 1st PhD supervisor: 'An exploratory case-control study of myeloproliferative neoplasms', QUB 2012-2015. Funded: MPN Voice.
- 1st PhD supervisor: 'Prior medical history, drug exposure and risk of multiple myeloma', QUB 2011-2013. Funded: DEL.
- 3rd PhD supervisor: ‘Investigating the association between aspirin & non-steroidal anti-inflammatory drugs and head and neck cancer & malignant melanoma’, QUB 2009-2011. Funded: DEL.
Masters
- 1st supervisor, MSc in Public Health: ‘Assessing breast density in women attending for breast screening’, University of Aberdeen, 2024.
- 1st supervisor, MSc in Public Health: ‘Assessing knowledge and attitudes to artificial intelligence use in medical x-rays’, University of Aberdeen, 2022.
- 1st supervisor, MSc in Public Health: ‘Analysing the impact of social factors and distance to care on breast cancer outcomes in Scotland’, University of Aberdeen, 2021.
- 1st supervisor, MSc in Health Data Science: ‘Are Gluten-Free Foods Unhealthy?’, University of Aberdeen, 2021.
- 1st supervisor, MSc in Public Health: ‘Assessing the impact of COVID-19 on the quality of life of patients with a Myeloproliferative Neoplasm’, QUB 2020.
- 1st supervisor, MSc in Bioinformatics and computational genomics: ‘Natural Language Processing Tool for Breast Cancer Registration’, QUB 2020.
- 1st supervisor, MSc in Public Health: ‘Systematic review of arts-based approaches to increase awareness of breast cancer’, QUB 2019.
- 1st supervisor, MSc in Public Health: ‘Knowledge and attitudes of HPV in Angola’, QUB 2018.
- 1st supervisor, MSc in Public Health: ‘Attitudes and knowledge of parents to HPV vaccination – a quantitative investigation’, QUB 2016.
- 1st supervisor, MSc in Public Health: ‘Assessing the impact of MGUS’, QUB 2015.
- 1st supervisor, MSc in Public Health: ‘Anti-diabetic medications & risk of MGUS/myeloma’, QUB 2014.
- 1st supervisor, MSc in Public Health: ‘Investigating birth factors and Hodgkin lymphoma’, QUB 2010.
- 1st supervisor, MSc in Public Health.: ‘Investigating incidence trends of Human papillomavirus related and unrelated head and neck cancers’, QUB 2010.
- 1st supervisor, MPH: 'Determination of the predictors of Acute Human Immunodeficiency Virus type 1 and 2 for the targeted screening using p24 Enzyme Linked Immunosorbent Assay: a retrospective study from populations in Kenya, South Africa and Uganda' University of Liverpool, 2010.
Undergraduate
- 1st supervisor, Public Health ‘Attitudes and behaviours regarding tanning in Northern Ireland: A mixed-methods study of Queen’s University of Belfast students.’ UoA 2021-2022.
- 1st supervisor, Human Biology ‘Attitudes and behaviours regarding tanning in Northern Ireland: A mixed-methods study of Queen’s University of Belfast students.’ QUB 2017-2018.
- 1st supervisor, Human Biology ‘Coeliac Disease – Diagnosis, Trends, Cancer Risk and Mortality’ QUB 2017-2018.
- 2nd supervisor, Human Biology ‘Gluten Free’ Food for Thought.’ QUB 2018-2019.
- 1st supervisor, Human Biology ‘Occupational risk factors for myeloproliferative neoplasms.’ QUB 2017-2018.
- 1st supervisor, Human Biology ‘Incidence of Paediatric Cancer in Africa: a systematic review.’ QUB 2017-2018.
- 2nd supervisor, Human Biology ‘Knowledge, Attitudes & Practice of Paediatric Cancer in Africa: a systematic review’ QUB 2017-2018.
- 1st supervisor, Human Biology ‘Parental knowledge & attitudes to HPV vaccination.’ QUB 2016-2017.
- 1st supervisor, Human Biology ‘Oral dysplasia transformation rate’. QUB 2015/16.
- 1st supervisor, Human Biology ‘Incidence, prevalence and survival of MGUS’ QUB 2015-2016.
- 1st supervisor, Biomedical Science ‘Human Papilloma virus in head and neck cancers’, 2012-2013.
- 1st supervisor, Biomedical Science ‘Langerhans’ cells and immune response biomarkers in head and neck cancers’, 2012-2013.
- 1st supervisor, BSc Anatomy ‘Investigating psychological risk factors for oesophageal adenocarcinoma’, QUB 2010-2011.
- 1st supervisor, BSc Anatomy ‘Investigating survival differences between HPV-related and unrelated head and neck cancers’, QUB 2010-2011.
Funding and Grants
Current Research
- Anderson (PI), De Vries, Lip, Staff. ANCHOR Breast imaging dataset. Friends of Anchor, 2024 £69,408.96.
- Anderson (PI), De Vries, D’Ambruoso, Adamczyk, Lip, Arumapperuma, Camanda. Implementing Artificial Intelligence-enabled thermal imaging and ultrasound to detect breast cancer in low and middle income settings. International Science Partnerships Fund (ISPF) ODA Project Grants £19,981.78.
- Anderson (PI), McShane, McMullin, McKnight. MPN Discovery - assessing gene-environment interaction. Blood Cancer UK. 2023-2026. £277,666.11.
- Anderson (PI), Toenail trace elements for assessing risk of myeloproliferative neoplasms. Friends of Anchor, 2023-2024. £11,193.
- Anderson (PI), Abutheraa N, Iversen L, Robertson C, Tarburn E. Investigating the incidence, prevalence and outcomes of myeloproliferative neoplasms to aid service planning and delivery in NHS Grampian. NHS Endowments, 2023-2024. £18,837.
- Anderson (PI), Lip (CI), Staff, De Vries. Grampian's Evaluation of Mia an Innovative National Breast Screening Initiative. Kheiron Medical Technologies Limited under NIHR Phase 4 AI Award. 2022-2024, £413,689.
- Omar, Anderson (Co-I), MacLennan, MacLennan, Speirs & European Association of Urology Guidelines Office. Optimal treatment for patients with solid tumours in Europe through artificial intelligence.. European Commission, 2021-2026, €10,459,997.00 (£565,400 to UoA). Part of the 21.3 million Euro project. https://www.optima-oncology.eu/
- Farrow, Anderson (Co-I) & Ashcroft. ARCHERY PROJECT: AI TO REVOLUTIONISE THE PATIENT CARE PATHWAY IN HIP AND KNEE ARTHROPLASTY. Chief Scientist Office, Scotland, 2021-2024, £237,568.
- MOSAICC study : Anderson (PI). MOSAICC (MyelOproliferative neoplasmS: An In-depth Case-Control) study in Aberdeen. Friends of Anchor, 2021-2023. £22,064; Anderson (PI), McShane, Mc Mullin, Duncombe, Fritschi, DeVocht, Mesa. MOSAICC study. MPN Voice. 2021-2023. £75,631; McShane, Anderson (Co-I), McMullin. MOSAICC study. Leukaemia and Lymphoma NI, £47,000. 2021-2022; Anderson (PI). MOSAICC Ireland, Mercy Hospital Foundation. 2023-2024, £49177.89.
- McShane, Gavin, Anderson (Co-I). Investigating the impact of geographic inequalities and local service provision on multiple myeloma patient outcomes within the UK. Myeloma UK, 2021-2023. £100,000.
Prior Research (last 5 years)
- Elsberger, Anderson (Co-I), Scottish National Audit of Breast Cancer in Older Patients (S_NABCOP). NHSG Endownment Breast Cancer Research Fund 2022-2023, £13,422.
- Abderson (PI), Abutheraa N. Using Occupational Integrated Database Exposure Assessment (OccIDEAS) to assess occupational exposure risk for MyeloProliferative Neoplasms (MPN) patients and their control: A comparison study. University of Aberdeen Internal Funding to Pump-Prime Research and Research Networks. 2023. £9,931.75.
- Harrison, Blackwood, Anderson (Co-I). The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics https://icaird.com/. Extension bid (2022-2023). Innovate UK. £1,611,191. Total iCAIRD project grant £9,970,020 (UoA total: £394,477).
- Anderson (PI), D’Ambruoso, Camanda, Buco, Chocolate, Lohfeld. Evaluating opportunities and barriers to establishing an autonomous and functional sickle cell anaemia (SCA) unit in Cabinda, Angola. Scottish Funding Council, 2020-2021, £45,563.
- Murchie, Anderson (Co-I), Analysing NCDA data to support the adoption of Early Cancer Diagnostic Centres in Scotland. Chief Scientist Office, Scotland, 2021. £50,000.
- Black, Anderson (Co-I), Fluck, Hollick, Nath, Sawhney. MINIMISING IMPACT ON VULNERABLE PATIENTS: DATA DRIVEN DESIGN, MONITORING AND ADAPTATION OF COVID AND NON-COVID CLINICAL CARE PATHWAYS. Chief Scientist Office, Scotland. 2020. £61,452.
- McShane, Kunzmann, Anderson (Co-I), Lohfeld, Donnelly, Bayarmongol, Jigjidsuren, Enkhjargal, Tudev, Badamsuren, Jugder. Reducing cancer burden in Mongolia: Co-developing an Evidence-based Plan to Strengthen the Health Care System and Inform Policy. NIHR, £93,487.
- Gavin, Anderson (Co-I). Northern Ireland Colorectal cancer Audit, Public Health Agency NI, £81,531.
- Gavin, Anderson (Co-I). Northern Ireland Cancer Registry, Public Health Agency NI, £823,560.
- Gavin, Anderson (Co-I). Northern Ireland Cardiovascular Registry. Heart Research UK, 2019-2021. £149,991.
- Lohfeld, Anderson (Co-I), Santin, Donnelly, Franziska, Jenkins, Burgess, Nguyen, Murphy, Hang, Truong, Schroeder, Hang. Documenting how the arts and storytelling can save lives: The Viet Nam Breast Cancer project, MRC-AHRC. 2018-2020. £165,416.
- Lohfeld, Anderson (Co-I), Promoting Sustainable Health and Wellbeing in Angola. 2018-2019, Department for the Economy Northern Ireland, £52,793.
- Teaching
-
Teaching Responsibilities
PhD Opportunities
Supervising students with an interest in Health Data Science and cancer research. Please contact lesley.anderson@abdn.ac.uk
- Publications
-
Page 1 of 2 Results 1 to 100 of 196
The Clinical Practice Integration of Artificial Intelligence (CPI-AI) framework: a proposed application of IDEAL principles to artificial intelligence applications in trauma and orthopaedics
Bone & Joint Research, vol. 13, no. 9, pp. 507-512Contributions to Journals: ArticlesTNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinoma
European Journal of Cancer, vol. 211, 114329Contributions to Journals: ArticlesTrends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021
Scientific Reports, vol. 14, no. 1, 19069Contributions to Journals: ArticlesPathways to MPN presentation and time-to-diagnosis: results from a cross-sectional study
BJGP OpenContributions to Journals: ArticlesAutoimmune Conditions and Gastric Cancer Risk in a Population-based Study in the United Kingdom
British Journal of Cancer, vol. 131, pp. 138-148Contributions to Journals: ArticlesPathways to MPN Presentation and Diagnosis: Results from a Cross-Sectional Study
BJGP OpenContributions to Journals: ArticlesA stakeholder analysis to prepare for real-world evaluation of integrating artificial intelligent algorithms into breast screening (PREP-AIR study): a qualitative study using the WHO guide
BMC Health Services Research, vol. 24, no. 1, 569Contributions to Journals: ArticlesService and clinical impacts of reader bias in breast cancer screening: a retrospective study
British Journal of Radiology, vol. 97, no. 1153, pp. 120-125Contributions to Journals: ArticlesRevisiting Cancer Diagnosis in Scotland: Further Insights from the Second Scottish National Cancer Diagnosis Audit
European Journal of Cancer Care, vol. 2024, 1117968Contributions to Journals: ArticlesThe aetiology and burden of myeloproliferative neoplasms in the United Kingdom: the MyelOproliferative neoplasmS: an In-depth case-control (MOSAICC) study protocol.
BMC Cancer, vol. 23, 1207Contributions to Journals: ArticlesThe JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden
European Journal of Haematology, vol. 4, no. 4, pp. 1071-1080Contributions to Journals: ArticlesThe Impact of Rurality on Patient Experience and Diagnostic Pathway Intervals in Scotland’s Cancer Patients: Further Results from a National Cancer Diagnosis Audit Cancer Epidemiology
Cancer Epidemiology, vol. 86, 102414Contributions to Journals: ArticlesImpact of Different Mammography Systems on Artificial Intelligence Performance in Breast Cancer Screening
Radiology: Artificial Intelligence, vol. 5, no. 3, e220146Contributions to Journals: ArticlesAI in breast screening mammography: breast screening readers' perspectives
Insights into Imaging, vol. 13, no. 1, 186Contributions to Journals: ArticlesPrioritization of THose aWaiting hip and knee ArthroplastY(PATHWAY): protocol for development of a stakeholder led clinical prioritization tool
Bone & Joint Open, vol. 3, no. 10, pp. 753-758Contributions to Journals: ArticleseQTL set-based association analysis identifies novel susceptibility loci for Barrett's esophagus and esophageal adenocarcinoma
Cancer Epidemiology, Biomarkers and Prevention, vol. 31, no. 9, cebp.0096Contributions to Journals: ArticlesSupporting someone with cancer during the COVID-19 pandemic: A mixed methods analysis of cancer carer's health, Quality of Life and need for support
Health & Social Care in the Community, vol. 30, no. 5, pp. e3246-e3252Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/hsc.13768
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/19209/1/Santin_etal_HSC_Supporting_Someone_With_VoR.pdf
- [ONLINE] View publication in Scopus
- [ONLINE] View publication in Mendeley
Evaluation of Human Papillomavirus (HPV) Knowledge among Healthcare Professionals: A study of conference attendees in Angola
Global Public HealthContributions to Journals: ArticlesUsing Artificial Intelligence to Revolutionise the Patient Care Pathway in Hip and Knee Arthroplasty (ARCHERY): Protocol for the Development of a Clinical Prediction Model
JMIR Research Protocols, vol. 11, no. 5, e37092Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.2196/37092
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/18857/1/Farrow_et_al_Using_Artificial_JMIR_vor.pdf
- [ONLINE] View publication in Scopus
Spatial disparities in the reported incidence and survival of myeloproliferative neoplasms in Australia
Pathology, vol. 54, no. 3, pp. 328-335Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.pathol.2021.06.122
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/20358/2/Supplement_MPNs_spatial_epi.pdf
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/20358/3/MPN_spatial_epi_FINAL.pdf
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/20358/1/MPNs_estimates.xlsx
A National Network of Safe Havens: Scottish Perspective
Journal of Medical Internet Research, vol. 24, no. 3, pp. e31684Contributions to Journals: ArticlesMenopausal hormone therapy and risk of biliary tract cancers
Hepatology, vol. 75, no. 2, pp. 309-321Contributions to Journals: ArticlesNot all small HER2 positive breast cancers have the same clinical outcome in the North-East of Scotland
Cancer Treatment and Research Communications, vol. 31, no. 2022, 100549Contributions to Journals: ArticlesInterpretation and Reporting of Predictive or Diagnostic Machine Learning Research in Trauma & Orthopaedics
Bone and Joint Journal, vol. 103B, no. 12, pp. 1754-1758Contributions to Journals: ArticlesA systematic review and meta-analysis of cancer risk in myotonic dystrophy: consistent with a general increased risk of cancer
Neuromuscular Disorders, vol. 31, no. Supplement 1, S121Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1016/j.nmd.2021.07.261
The psychosocial impact of the COVID-19 pandemic on MGUS, smouldering and active myeloma patients: findings from an international survey
British Journal of Haematology, vol. 194, no. 2, pp. 294-297Contributions to Journals: LettersDoes risk of progression from Barrett’s esophagus to esophageal adenocarcinoma change based on the number of non-dysplastic endoscopies?
Digestive Diseases and Sciences, vol. 66, pp. 1965–1973Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s10620-020-06483-0
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/16835/1/Barretts.pdf
- [ONLINE] View publication in Scopus
Patient's perspectives of living with a precancerous condition: monoclonal gammopathy of undetermined significance (MGUS)
European Journal of Oncology Nursing, vol. 51, 101901Contributions to Journals: ArticlesGermline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma
Carcinogenesis, vol. 42, no. 3, pp. 369-377Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1093/carcin/bgaa132
Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients
62nd American Society of Hematology Annual Meeting and ExpositionContributions to Conferences: Abstracts- [ONLINE] Abstract
Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma
Gastroenterology, vol. 159, no. 6, pp. 2065-2076.E1Contributions to Journals: ArticlesAssociation Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus
Clinical Gastroenterology and Hepatology, vol. 18, no. 12, pp. 2701-2709.e3Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.cgh.2019.11.030
- [ONLINE] View publication in Scopus
Changes in the Demographic and Clinicopathological Characteristics of Thyroid Cancer: A Population-Based Investigation in Algeria, 1993-2013
Journal of Cancer Epidemiology, vol. 2020, 7812791Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1155/2020/7812791
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/15194/2/Article_Boukheris_et_al._IJC_Houda_Revised.docx
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/15194/1/Boukheris_et_al_JOCE_ChangesInTheDemogrphic_VoR.pdf
- [ONLINE] View publication in Scopus
Rare thyroid malignancies in Europe: data from the information network on rare cancers in Europe (RARECAREnet)
Oral Oncology, vol. 108, 104766Contributions to Journals: ArticlesAetiology of Myeloproliferative Neoplasms
Cancers, vol. 12, no. 7, pp. 1-11Contributions to Journals: Review articlesCancer incidence projections in Northern Ireland to 2040
Cancer Epidemiology, Biomarkers and Prevention, vol. 29, no. 7, pp. 1398-1405Contributions to Journals: ArticlesModifiable lifestyle and medical risk factors associated with myeloproliferative neoplasms
HemaSphere, vol. 4, no. 1, e327Contributions to Journals: ArticlesComparison of molecular assays for HPV testing in oropharyngeal squamous cell carcinomas: A population-based study in Northern Ireland
Cancer Epidemiology Biomarkers and Prevention, vol. 29, no. 1, pp. 31-38Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1158/1055-9965.EPI-19-0538
- [ONLINE] View publication in Scopus
- [ONLINE] Deposit in QUB repository
Improving identification of cognitive impairment in fragility fracture patients: impact of educational guidelines on current practice
Geriatric orthopaedic surgery & rehabilitation, vol. 11, pp. 1-7Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1177/2151459320935095
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/15118/2/Submitted_manuscript_Improving_screening_for_cognitive_impairment_manuscript.docx
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/15118/1/Kennedy_etal_GOSR_Improving_identification_VOR.pdf
- [ONLINE] View publication in Scopus
Diabetes in relation to Barrett’s esophagus and adenocarcinomas of the esophagus: a pooled study from the International Barrett’s and Esophageal Adenocarcinoma Consortium
Cancer, vol. 125, no. 23, pp. 4210-4223Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/cncr.32444
- [ONLINE] QUB Repository
Association between aspirin use and biliary tract cancer survival
JAMA Oncology, vol. 5, no. 12, pp. 1802-1804Contributions to Journals: LettersNo Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study
Clinical Gastroenterology and Hepatology, vol. 17, no. 11, pp. 2227-2235Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.cgh.2019.01.041
- [ONLINE] View publication in Scopus
Benign tumors in myotonic dystrophy type I target disease-related cancer sites
Annals of Clinical and Translational Neurology, vol. 6, no. 8, pp. 1510-1518Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/acn3.50856
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/14586/1/Alsagaff_etal_ACTN_Benign_Tumors_VOR.pdf
- [ONLINE] View publication in Scopus
Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink
Gut, vol. 68, no. 8, pp. 1458-1464Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/gutjnl-2018-317504
- [ONLINE] QUB repository
Predictors of an early death in patients diagnosed with colon cancer: A retrospective case-control study in the UK
BMJ Open, vol. 9, no. 6, e026057Contributions to Journals: ArticlesRecommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach
British Journal of Cancer, vol. 120, pp. 827-833Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/s41416-019-0414-9
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/14591/1/Craig_BJC_Recommendations_VOR.pdf
- [ONLINE] View publication in Scopus
Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014
American Journal of Hematology, vol. 94, no. 4, pp. E107-E109Contributions to Journals: Letters- [ONLINE] DOI: https://doi.org/10.1002/ajh.25407
- [ONLINE] View publication in Scopus
Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors
Gastroenterology, vol. 156, no. 1, pp. 43-45Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1053/j.gastro.2018.09.038
- [ONLINE] View publication in Scopus
- [ONLINE] Deposit in Queen's University Belfast repository
Communication strategies for rare cancers: A systematic review protocol
Systematic reviews , vol. 8, 102Contributions to Journals: Review articlesLow knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among general practitioners
BMC Family Practice, vol. 20, 61Contributions to Journals: ArticlesInteractions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus
Clinical Gastroenterology and Hepatology, vol. 16, no. 10, pp. 1598-1606.e4Contributions to Journals: ArticlesHelicobacter pylori Infection Is Associated With Reduced Risk of Barrett’s Esophagus: An Analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium
American journal of gastroenterology, vol. 113, no. 8, pp. 1148-1155Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/s41395-018-0070-3
- [ONLINE] View publication in Scopus
Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma
Clinical Gastroenterology and Hepatology, vol. 16, no. 8, pp. 1229-1236.e4Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.cgh.2018.03.014
- [ONLINE] View publication in Scopus
Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink
British Journal of Haematology, vol. 181, no. 4, pp. 505-514Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/bjh.15229
- [ONLINE] View publication in Scopus
Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants
Gastroenterology, vol. 154, no. 5, pp. 1273-1281.e3Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1053/j.gastro.2017.12.003
- [ONLINE] View publication in Scopus
- [ONLINE] University of Cambridge Institutional Repository
Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink
International Journal of Cancer, vol. 142, no. 6, pp. 1174-1181Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/ijc.31143
- [ONLINE] View publication in Scopus
The MOSAICC study: Assessing feasibility for biological sample collection in epidemiology studies and comparison of DNA yields from saliva and whole blood samples
Annals of Human Genetics, vol. 82, no. 2, pp. 114-118Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/ahg.12227
- [ONLINE] View publication in Scopus
Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study
PloS ONE, vol. 13, no. 1, e0190325Contributions to Journals: ArticlesMonoclonal gammopathy of undetermined significance as viewed by haematology healthcare professionals
European Journal of Haematology, vol. 100, no. 1, pp. 20-26Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/ejh.12962
- [ONLINE] View publication in Scopus
Hormone replacement therapy and risk of multiple myeloma and monoclonal gammopathy of undetermined significance (MGUS) in the UK Clinical Practice Research Datalink
Contributions to Conferences: PapersHormonal and reproductive factors and subsequent risk of haematological malignancies: findings from the UK Biobank
Contributions to Conferences: PostersINCIDENCE AND PREVALENCE OF SICKLE CELL DISEASE. A SYSTEMATIC REVIEW AND META-ANALYSIS
Haematology Association Ireland Annual Meeting 2017Contributions to Conferences: PostersKnowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among General Practitioner’s.
Haematology Association Ireland Annual Meeting 2017Contributions to Conferences: PostersLiving with MGUS. How does it compare to the other premalignant conditions?
Contributions to Conferences: PapersKnowledge or noise? Making sense of General Practitioners’ and Consultant use of two-week-wait referrals for suspected cancer
British Journal of Cancer, vol. 117, no. 5, pp. 597-603Contributions to Journals: ArticlesBurden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
Lancet Oncology, vol. 18, no. 8, pp. 1022-1039Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S1470-2045(17)30445-X
- [ONLINE] Queen's University Belfast repository
The prevalence of viral agents in esophageal adenocarcinoma and Barrett's esophagus: A systematic review
European Journal of Gastroenterology and Hepatology, vol. 29, no. 7, pp. 817-825Contributions to Journals: Review articles- [ONLINE] DOI: https://doi.org/10.1097/MEG.0000000000000868
- [ONLINE] View publication in Scopus
External Validation of the Michigan Barrett's Esophagus Prediction Tool
Clinical Gastroenterology and Hepatology, vol. 15, no. 7, pp. 1124-1126Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.cgh.2017.03.004
- [ONLINE] View publication in Scopus
- [ONLINE] Queen's University Belfast's research archive page
Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: A population-based case-control study
British Journal of Nutrition, vol. 117, no. 9, pp. 1323-1331Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1017/S0007114517001131
- [ONLINE] View publication in Scopus
- [ONLINE] Deposit in Queen's University Belfast
Sex steroid hormones in relation to Barrett’s esophagus: An analysis of the FINBAR study
Andrology, vol. 5, no. 2, pp. 240-247Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/andr.12314
- [ONLINE] View publication in Scopus
Net survival in peripheral T-cell lymphoma in Europe between 2000 and 2007: results from the Rarecarenet database
Contributions to Conferences: PapersVulnerability to anti-vaccine campaigns in Ireland..could it be low knowledge?
Contributions to Conferences: PapersNonsteroidal anti-inflammatory drug use is not associated with reduced risk of Barrett's Esophagus
American journal of gastroenterology, vol. 111, no. 11, pp. 1528-1535Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/ajg.2016.348
- [ONLINE] View publication in Scopus
HOW COMMON IS MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)? A SYSTEMATIC REVIEW
Contributions to Conferences: PapersGenome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis
The Lancet Oncology, vol. 17, no. 10, pp. 1363-1373Contributions to Journals: ArticlesInverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis
Clinical Gastroenterology and Hepatology, vol. 14, no. 10, pp. 1412-1419.e3Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.cgh.2016.05.032
- [ONLINE] View publication in Scopus
A Systematic Review On Monoclonal Gammopathy Of Undetermined Significance (MGUS) Survival
Contributions to Conferences: PapersESTABLISHING A POPULATION-BASED REGISTER OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE IN NORTHERN IRELAND
Contributions to Conferences: PapersLIFESTYLE AND MEDICAL RISK FACTORS ASSOCIATED WITH MYELOPROLIFERATIVE NEOPLASMS: RESULTS FROM THE PILOT MOSAICC STUDY
Contributions to Conferences: PapersMinor allele frequency of myeloproliferative neoplasm mutations in the Irish blood donor population
Hematological Oncology, vol. 34, no. 3, pp. 161-164Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/hon.2190
- [ONLINE] View publication in Scopus
Constrained Score Statistics Identify Genetic Variants Interacting with Multiple Risk Factors in Barrett's Esophagus
American Journal of Human Genetics, vol. 99, no. 2, pp. 352-365Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.ajhg.2016.06.018
- [ONLINE] View publication in Scopus
HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland
Journal of Medical Virology, vol. 88, no. 7, pp. 1262-1270Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/jmv.24447
- [ONLINE] View publication in Scopus
The prevalence of Infectious agents in oesophageal adenocarcinoma: a systematic review
Contributions to Conferences: PapersPatient perspectives of a diagnosis of myeloproliferative neoplasm in a case control study
Experimental Hematology and Oncology, vol. 5, no. 1, 14Contributions to Journals: ArticlesDietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett’s oesophagus and oesophageal adenocarcinoma: A population-based case-control study
British Journal of Nutrition, vol. 115, no. 2, pp. 342-350Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1017/S0007114515004444
- [ONLINE] View publication in Scopus
Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium
International Journal of Cancer, vol. 138, no. 1, pp. 55-64Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/ijc.29688
- [ONLINE] View publication in Scopus
MYELOPROLIFERATIVE NEOPLASM PATIENT SYMPTOM BURDEN AND QUALITY OF LIFE: EVIDENCE OF SIGNIFICANT IMPAIRMENT COMPARED TO CONTROLS USING MULTIVARIATE ANALYSIS
Contributions to Conferences: PapersMYELOPROLIFERATIVE NEOPLASM SYMPTOM BURDEN AND QUALITY OF LIFE: RESULTS FROM THE PILOT MOSAICC STUDY
Contributions to Conferences: PapersMyeloproliferative Neoplasm Patient Symptom Burden and Quality of Life: Evidence of Significant Impairment Compared to Controls Using Multivariate Analysis
Contributions to Conferences: PapersMyeloproliferative neoplasms: an in-depth case-control study
ASH - American Society of Hematology 57th Annual Meeting and ExpositionContributions to Conferences: PostersPrognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
European Journal of Cancer, vol. 51, no. 15, pp. 2130-2143Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.ejca.2015.07.043
- [ONLINE] View publication in Scopus
Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5
European Journal of Cancer, vol. 51, no. 15, pp. 2144-2157Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.ejca.2015.07.026
- [ONLINE] View publication in Scopus
Myeloproliferative neoplasm patient symptom burden and quality of life: Evidence of significant impairment compared to controls
American Journal of Hematology, vol. 90, no. 10, pp. 864-870Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/ajh.24098
- [ONLINE] View publication in Scopus
Is Europe doing better in cancer care since the 90s? The latest findings from the EUROCARE-5 study
18th ECCO - 40th ESMO European Cancer CongressContributions to Conferences: PostersErratum: How common are myeloproliferative neoplasms? A systematic review and meta-analysis [Am. J. Hematol. 89:581-587, 2014. DOI: 10.1002/ajh.23690]
American Journal of Hematology, vol. 90, no. 9, pp. 850Contributions to Journals: Comments and Debates- [ONLINE] DOI: https://doi.org/10.1002/ajh.23984
- [ONLINE] View publication in Scopus
Establishing a population-based register of monoclonal gammopathy of undetermined significance (MGUS) in Northern Ireland
Contributions to Conferences: Papers- [ONLINE] DOI: https://doi.org/10.1111/ecc.12330
Myeloproliferative neoplasm patients experience significant symptom burden.
NCIN Cancer Outcomes ConferenceContributions to Conferences: PostersFeatures of the diagnostic pathway associated with early death from colon cancer: A nested case-control study in a UK region
European Journal of Cancer Care, vol. 24, no. Supplement S1, pp. 5Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/ecc.12329
Risk of myeloid neoplasms after solid organ transplantation
Leukemia, vol. 28, pp. 2317-2323Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/leu.2014.132
- [ONLINE] View publication in Scopus
Alcohol and the Risk of Barrett's Esophagus: A Pooled Analysis from the International BEACON Consortium
American journal of gastroenterology, vol. 109, pp. 1586-1594Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/ajg.2014.206